Journal of Jilin University(Medicine Edition) ›› 2022, Vol. 48 ›› Issue (3): 561-567.doi: 10.13481/j.1671-587X.20220302
• Research in basic medicine • Previous Articles Next Articles
Yifan ZHANG,Jie DING,Min DU,Xiaoteng FENG,Ping LIU(
)
Received:2021-09-28
Online:2022-05-28
Published:2022-06-21
Contact:
Ping LIU
E-mail:liuping0207@126.com
CLC Number:
Yifan ZHANG,Jie DING,Min DU,Xiaoteng FENG,Ping LIU. Effects of salvianolic acid B on atherosclerosis and efferocytosis of macrophages of mice and their mechanisms[J].Journal of Jilin University(Medicine Edition), 2022, 48(3): 561-567.
Tab. 1
Primer sequences of RT-qPCR"
| Gene | Primer | Length(bp) |
|---|---|---|
| β-actin | F:5'-GAGACCTTCAACACCCCAGC-3' R:5'-ATGTCACGCACGATTTCCC-3' | 20 19 |
| AXL | F:5'-GAGCCAACCGTGGAAAGA-3' R:5'-AGGCCACCTTATGCCGATCTA-3' | 19 21 |
| MERTK | F:5'-AGTTTGGGACGTTGGTGGAT-3' R:5'-GGACACCGTCAGTCCTTTGT-3' | 20 20 |
| TYRO3 | F:5'-ACTGGCTTCTCTGCTGCTC-3' R:5'-AGCATCAGACCGTTCCACTG-3' | 19 20 |
| MFGE8 | F:5'-TGACTTTGGACACACAGCGT-3' | 20 |
| R:5'-GGGAGGCTAGGTTGTTGGAAA-3' | 21 |
Tab. 4
Expression levels of AXL, MERTK, TYRO3,and MFGE8 mRNA in arterial tissue of mice in various groups"
| Group | AXL | MERTK | TYRO3 | MFGE8 |
|---|---|---|---|---|
| Control | 1.23±0.43 | 1.05±0.51 | 1.08±0.48 | 0.95±0.37 |
| Model | 0.48±0.10** | 0.37±0.24** | 0.60±0.11* | 0.36±0.11** |
| Sal B | 0.85±0.14△ | 0.79±0.13△ | 0.80±0.13△ | 0.66±0.16△ |
| Atorvastatin | 1.35±0.31△△ | 0.87±0.21△△ | 0.93±0.17△ | 0.65±0.19△ |
Tab. 5
Expression levels of AXL, MERTK, TYRO3,and MFGE8 mRNA in RAW264.7 cells in various groups"
| Group | AXL mRNA | MERTK mRNA | TYRO3 mRNA | MFGE8 mRNA |
|---|---|---|---|---|
| Control | 1.09±0.46 | 1.09±0.48 | 1.29±0.01 | 0.96±0.22 |
| ox-LDL induction | 0.25±0.07* | 0.24±0.04* | 0.55±0.12* | 0.22±0.02* |
| Sal B | ||||
| Low dose | 0.27±0.15△ | 0.71±0.15△ | 1.06±0.30△ | 0.60±0.17△ |
| Middle dose | 0.84±0.25△ | 0.78±0.18△ | 1.16±0.06△ | 0.80±0.20△ |
| High dose | 0.46±0.10△ | 1.36±0.21△△ | 1.43±0.74△ | 0.65±0.30△ |
| 1 | LU H, DAUGHERTY A. Atherosclerosis[J]. Arterioscler Thromb Vasc Biol, 2015, 35(3): 485-491. |
| 2 | LI Y T, LI Q Q, FAN G C. Macrophage efferocytosis in cardiac pathophysiology and repair[J]. Shock, 2020, 55(2): 177-188. |
| 3 | XIAO Z, LIU W, MU Y P, et al. Pharmacological effects of salvianolic acid B against oxidative damage[J]. Front Pharmacol, 2020, 11: 572373. |
| 4 | KO Y S, JIN H N, PARK S W, et al. Salvianolic acid B protects against oxLDL-induced endothelial dysfunction under high-glucose conditions by downregulating ROCK1-mediated mitophagy and apoptosis[J]. Biochem Pharmacol, 2020, 174: 113815. |
| 5 | SUN J M, HO C K, GAO Y, et al. Salvianolic acid-B improves fat graft survival by promoting proliferation and adipogenesis[J]. Stem Cell Res Ther,2021,12(1): 507. |
| 6 | 陈 雪, 沈 楠, 安 英, 等. 丹酚酸B对氧化应激损伤乳鼠心肌细胞的保护作用及其机制[J]. 吉林大学学报(医学版), 2018, 44(5): 974-978. |
| 7 | YANG Y, PEI K, ZHANG Q, et al. Salvianolic acid B ameliorates atherosclerosis via inhibiting YAP/TAZ/JNK signaling pathway in endothelial cells and pericytes[J]. Biochim Biophys Acta Mol Cell Biol Lipids, 2020, 1865(10): 158779. |
| 8 | YANG T L, LIN F Y, CHEN Y H, et al. Salvianolic acid B inhibits low-density lipoprotein oxidation and neointimal hyperplasia in endothelium-denuded hypercholesterolaemic rabbits[J]. J Sci Food Agric, 2011, 91(1): 134-141. |
| 9 | BAO Y, WANG L, XU Y N, et al. Salvianolic acid B inhibits macrophage uptake of modified low density lipoprotein (mLDL) in a scavenger receptor CD36-dependent manner[J]. Atherosclerosis, 2012, 223(1): 152-159. |
| 10 | YUE J M, LI B, JING Q P, et al. Salvianolic acid B accelerated ABCA1-dependent cholesterol efflux by targeting PPAR-γ and LXRα[J]. Biochem Biophys Res Commun, 2015, 462(3): 233-238. |
| 11 | LIN S J, LEE I T, CHEN Y H, et al. Salvianolic acid B attenuates MMP-2 and MMP-9 expression in vivo in apolipoprotein-E-deficient mouse aorta and in vitro in LPS-treated human aortic smooth muscle cells[J]. J Cell Biochem, 2007, 100(2): 372-384. |
| 12 | HANSSON G K, LIBBY P, TABAS I. Inflammation and plaque vulnerability[J].J Intern Med, 2015,278(5): 483-493. |
| 13 | DORAN A C, YURDAGUL A Jr, TABAS I. Efferocytosis in health and disease[J]. Nat Rev Immunol, 2020, 20(4): 254-267. |
| 14 | KOJIMA Y, WEISSMAN I L, LEEPER N J. The role of efferocytosis in atherosclerosis[J]. Circulation, 2017, 135(5): 476-489. |
| 15 | CAI B S, KASIKARA C. TAM receptors and their ligand-mediated activation: role in atherosclerosis[J]. Int Rev Cell Mol Biol, 2020, 357: 21-33. |
| 16 | AIT-OUFELLA H, POURESMAIL V, SIMON T, et al. Defective mer receptor tyrosine kinase signaling in bone marrow cells promotes apoptotic cell accumulation and accelerates atherosclerosis[J]. Arterioscler Thromb Vasc Biol, 2008, 28(8): 1429-1431. |
| 17 | THORP E, CUI D Y, SCHRIJVERS D M, et al. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of Apoe-/- mice[J]. Arterioscler Thromb Vasc Biol,2008,28(8):1421-1428. |
| 18 | HANAYAMA R, TANAKA M, MIWA K, et al. Identification of a factor that links apoptotic cells to phagocytes[J]. Nature, 2002, 417(6885): 182-187. |
| 19 | AIT-OUFELLA H, KINUGAWA K, ZOLL J, et al. Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice[J]. Circulation, 2007, 115(16): 2168-2177. |
| 20 | 袁得强,林 浩,朱国旗,等.自噬在动脉粥样硬化中的研究进展[J].同济大学学报(医学版),2022,43(1):138-144. |
| 21 | 郭中州,张亚南,刘季晨,等.PSRC1与ANXA2相互作用减缓动脉粥样梗化进展的作用机制[J]. 解放军医学杂志, 2021, 46(5): 440-447. |
| 22 | SCHRIJVERS D M, DE MEYER G R Y, KOCKX M M,et al. Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis[J]. Arterioscler Thromb Vasc Biol, 2005, 25(6): 1256-1261. |
| 23 | 韦 婧, 王建茹, 马贵萍, 等. 冠心康对LDLR-/-小鼠脾脏巨噬细胞胞葬作用的影响[J]. 上海中医药大学学报, 2018, 32(3): 56-61. |
| [1] | Jing YU,Yinzhuo HUANG,Zhongwei ZHOU,Yuxin XIE,Qian MAO. Analysis on influencing factors in type 2 diabetes mellitus patients complicated with lower limb atherosclerosis and construction of nomogram model [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 806-812. |
| [2] | Xiaoxia HU,Yalong LI,Dongliang YANG,Bazeren LA,Xinyue LIU. Effect of high glucose on polarization of Raw264.7 macrophages in vitro [J]. Journal of Jilin University(Medicine Edition), 2025, 51(2): 403-411. |
| [3] | Jiayuan YU,Di ZHAO,Xin JIANG,Jing XU,Lili JIANG,Hongyu JIANG. Association analysis on peripheral blood lymphocyte subsets and occurrence of carotid atherosclerosis [J]. Journal of Jilin University(Medicine Edition), 2024, 50(5): 1400-1405. |
| [4] | Xiaoyu WANG,Bing LI,Guohui LIU. Research progress in application of inflammatory markers in diagnosis and treatment of coronary heart disease [J]. Journal of Jilin University(Medicine Edition), 2024, 50(4): 1173-1181. |
| [5] | Shan CAO,Yijia ZHANG,Yang BAI,Fang CHEN,Sha XIE,Qianqian HAN. Network pharmacological analysis and in vitro experimental verification based on anti-atherosclerosis mechanism of Xiaoban Tongmai Formula [J]. Journal of Jilin University(Medicine Edition), 2024, 50(4): 925-938. |
| [6] | Haitao LI, Qin LI, Fei CAI, Guofu HU, Yunfei TENG. Effect of apigenin on polarization and inflammation of mouse RAW264.7 macrophages and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2023, 49(3): 549-556. |
| [7] | Shuhua YU,Wei LIU,Qianqian WU,Dongwei YANG. Effect of crocetin on vascular endothelial dysfunction and atherosclerosis in spontaneously hypertensive rats and its ROCK/JNK signaling pathway mechanism [J]. Journal of Jilin University(Medicine Edition), 2022, 48(6): 1481-1489. |
| [8] | Guowu WANG,Yuan YAO,Yu ZHANG,Na XU,Fang LIU. Inhibitory effect of miR-152 on proliferation and invasion of endometrial carcinoma cells by reducing low-density lipoprotein receptor expression [J]. Journal of Jilin University(Medicine Edition), 2022, 48(3): 591-599. |
| [9] | WANG Tu, SUN Xiaoxu, CHEN Long, CUI Haipeng, LIU Kai, XIE Yaqin, LI Ying, ZHAO Juan. Effect of Urantide on expression of c-Jun N-terminal kinase in thoracic aorta tissue of rats with atherosclerosis and its significance [J]. Journal of Jilin University(Medicine Edition), 2019, 45(04): 813-818. |
| [10] | ZHOU Licheng, LIU Xianfa, LI Qiang, LI Rong, HUANG Jiagan, ZHANG Qiong, LI Xiaofei. Anti-atherosclerosis effect of berberine combined with simvastatin in atherosclerosis model rats and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2019, 45(04): 849-854. |
| [11] | SUN Xiaoxu, WANG Tu, CUI Haipeng, LIU Kai, GAO Haicheng, ZHAO Juan. Effects of urantide on serum calcium, blood lipids and indexes of myocardial enzymes in rats with atherosclerosis [J]. Journal of Jilin University(Medicine Edition), 2019, 45(02): 331-335. |
| [12] | BI Hongdong, XIE Yaqin, CUI Haipeng, LIU Kai, SUN Xiaoxu, WANG Tu, ZHAO Juan. Effects of urantide on expressions of type Ⅳcollagenin thoracic aorta and VSMC of atherosclerotic rats [J]. Journal of Jilin University(Medicine Edition), 2019, 45(02): 342-346. |
| [13] | CHEN Xue, SHEN Nan, AN Ying, XU Bo, ZHAO Lijing. Protective effect of salvianolic acid B on cardiomyocytes of suckling rats with oxidative stress injuryand its mechanism [J]. Journal of Jilin University(Medicine Edition), 2018, 44(05): 974-978. |
| [14] | LIU Xiaojie, MEI Tao, MA Hongyan, YE Shandong. Analysis of influencing factors of carotid atherosclerosis plaque formation and stability in simple type 2 diabetic patients [J]. Journal of Jilin University Medicine Edition, 2018, 44(02): 350-355. |
| [15] | XU Jiguang, LI Yuning. Therapeutic effect of folic acid combined with vitamin B12 on atherosclerosis induced by hyperhomocysteinemia in rats [J]. Journal of Jilin University Medicine Edition, 2017, 43(05): 943-947. |